logo
Storz & Bickel Named 'Equipment Provider of the Year' at Business of Cannabis Awards 2025

Storz & Bickel Named 'Equipment Provider of the Year' at Business of Cannabis Awards 2025

Business Wire08-07-2025
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation ('Canopy Growth' or the 'Company') (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to share that Storz & Bickel has been awarded Equipment Provider of the Year at the 2025 Business of Cannabis Awards, held during the Cannabis Europa conference in London.
The award recognizes companies delivering best-in-class equipment across the cannabis value chain - from cultivation and extraction to packaging and vaporization. Winners are selected by a panel of independent industry judges following a multi-step evaluation based on written submissions.
Storz & Bickel's nomination, Pioneering Precision in Cannabis Vaporization, showcased the brand's nearly three-decade leadership in vaporization. Known for their engineering precision and product durability, highlights from the submission included:
The iconic VOLCANO tabletop vaporizer, launched in 2000 with patented convection technology.
The VENTY, released in 2024, offering rapid 20-second heat-up, adjustable airflow up to 20 L/min, and full temperature control.
Broad impact across both medical and recreational markets, with the VOLCANO MEDIC certified for medical use in several countries, as well as notable culinary applications by global chefs.
'Storz & Bickel continues to raise the bar for what's possible in vaporization technology,' said Luc Mongeau, Chief Executive Officer, Canopy Growth. 'This award is a testament to their commitment to innovation, precision, and delivering a world-class vaporization experience to adult consumers and patients around the world.'
Storz & Bickel's vaporizers are available in over 120 countries and trusted by medical patients and wellness consumers. Their reputation is built on precision engineering, product reliability, and compliance with international quality standards like ISO 13485.
'We're honored to be recognized with awards like these, which reflect the dedication of our entire team to pushing the boundaries of vaporization technology,' said Jürgen Bickel, Co-Founder and Managing Director, Storz & Bickel. 'From the VOLCANO to the VENTY, our focus has always been on engineering high-performance, reliable devices that meet the needs of patients and adult consumers around the world.'
The Business of Cannabis Award adds to a growing list of recent honours for Storz & Bickel. The VENTY was named 'Vaporizer of the Year' at The EMJAYs 1 and 'Best Portable Vaporizer' by Vaping360 2. The company also picked up American Accessory Brand of the Year from ADCANN 3 and its Marketing and PR efforts earned first prize at the 2024 MarCom Awards for event execution 4.
About Canopy Growth
Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives.
Through an unwavering commitment to our consumers, Canopy Growth delivers innovative products with a focus on premium and mainstream cannabis brands including Tweed, 7ACRES, DOJA, Deep Space and Claybourne, as well as category-defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA. Canopy USA's portfolio includes ownership of Acreage Holdings, a vertically integrated multi-state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Brands, a leading North American edibles brand, and majority ownership of Jetty Extracts, a California-based producer of high-quality cannabis extracts and clean vape technology.
At Canopy Growth, we're shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we're paving the way for a better understanding of all that cannabis can offer.
For more information visit www.canopygrowth.com.
About STORZ & BICKEL GmbH:
STORZ & BICKEL GmbH is the global leading manufacturer of high-end and medically certified cannabis vaporizers. With their commitment to quality, innovation, and compliance, the company has consistently delivered exceptional products that meet the highest industry standards. Based in Tuttlingen, Germany, STORZ & BICKEL continuously drives the advancement of vaporization technology, providing a safe and efficient means of consuming cannabis for medical purposes.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ncontracts Named to Inc. 5000 for a Seventh Consecutive Year
Ncontracts Named to Inc. 5000 for a Seventh Consecutive Year

Business Wire

time22 minutes ago

  • Business Wire

Ncontracts Named to Inc. 5000 for a Seventh Consecutive Year

BRENTWOOD, Tenn.--(BUSINESS WIRE)-- Ncontracts, the leading provider of integrated compliance, risk, and vendor management solutions to the financial services industry, today announced it has been ranked No. 3,068 on the 2025 Inc. 5000 list of the fastest-growing private companies in America. This marks the 7th consecutive year the company has earned a place on the prestigious list. This marks the 7th consecutive year the company has earned a place on the prestigious list. The Inc. 5000 recognizes independent businesses that have demonstrated exceptional revenue growth and innovation. Ncontracts' sustained presence on the list demonstrates Ncontracts' commitment to innovation and excellence in serving the evolving needs of financial institutions, mortgage companies, and registered investment advisors nationwide as they seek comprehensive, integrated solutions for their risk and compliance challenges. "This milestone reflects not just our growth, but our continued evolution as the industry's most trusted partner for integrated risk and compliance management,' said Michael Berman, founder and CEO of Ncontracts. 'As the risk landscape becomes increasingly complex, we remain committed to delivering innovative solutions that help our clients navigate these challenges with confidence." Today, Ncontracts serves more than 5,000 financial institutions, fintechs, mortgage companies, registered investment advisors, broker-dealers, trust companies, and other financial services organizations nationwide with solutions covering the full lifecycle of risk, compliance, and third-party risk management. The company's growth is driven by rising demand for integrated risk and compliance solutions, continued acquisitions in the governance, risk and compliance (GRC) space such as third-party risk management leader Venminder, and ongoing innovation, including the introduction of AI-powered tools. Ncontracts is a Preferred Service Provider (PSP) of The Independent Community Bankers of America (ICBA), a Premier Partner of the American Bankers Association's Partner Network, and endorsed by 11 state bank associations. Through a strategic agreement with America's Credit Unions, Ncomply, Ncontracts' flagship compliance management system, along with the company's complete portfolio of risk management solutions, will be promoted to help credit unions streamline operations and reduce costs. Financial organizations turn to Ncontracts to transform their enterprise risk and compliance management efforts. The platform's advanced tools simplify complex monitoring and reporting requirements while facilitating seamless risk communication throughout the organization. Through its knowledge-as-a-service (KaaS) approach, clients gain access to both sophisticated software and specialized expertise, creating a comprehensive solution that lightens compliance workloads and delivers the critical data needed for faster, more informed business decisions. This latest recognition builds on a strong foundation of workplace excellence awards that demonstrate the company's commitment to fostering an environment where both employees and the business can thrive. Earlier this year, the company was named a USA TODAY 2025 Top Workplace for the third year in a row and a Top Workplace by The Tennessean for a fifth consecutive year. About Ncontracts Ncontracts provides integrated risk management, compliance, and third-party risk management solutions to over 5,000 financial organizations including financial institutions, mortgage companies, registered investment advisors, and fintechs. Ncontracts solutions combine software with expert services to help financial organizations streamline risk and compliance management through an intuitive, cloud-based platform. Visit or follow the company on LinkedIn and X for more information.

Spectrum Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights
Spectrum Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights

Business Wire

time22 minutes ago

  • Business Wire

Spectrum Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights

LOS ANGELES--(BUSINESS WIRE)-- The DJS Law Group reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. ('Spectrum' or 'the Company') (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SPPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: DEADLINE: September 24, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Spectrum's Pinnacle Study of poziotinib for the treatment of lung cancer was less positive than it portrayed to investors. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate. NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of SPPI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case. WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results. Join the case to recover your losses. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store